Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]

8737 reported adverse events

Drugs of this class: DEXTROMETHORPHAN DEXTROMETHORPHAN POLISTIREX GUAIFENESIN AND DEXTROMETHORPHAN DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE

These side effects are most commonly reported by patients taking drugs of the Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 1604
1 DRUG ABUSE 729
2 TOXICITY TO VARIOUS AGENTS 702
3 OVERDOSE 615
4 DIZZINESS 516
5 DIARRHOEA 513
6 ACCIDENTAL OVERDOSE 406
7 COUGH 360
8 COMPLETED SUICIDE 355
9 DEATH 351
See all common reactions for Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]

Drugs of the Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EXPOSURE VIA INGESTION 38 0.0150
1 FACET JOINT SYNDROME 46 0.0141
2 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 95 0.0140
3 ACCIDENTAL OVERDOSE 406 0.0111
4 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 79 0.0110
5 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 61 0.0100
6 DRUG ABUSE 729 0.0087
7 RHEUMATIC FEVER 38 0.0085
8 SEROTONIN SYNDROME 163 0.0085
9 C-REACTIVE PROTEIN ABNORMAL 47 0.0073
See all enriched reactions for Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]